3Zipes, DP, Carom, AJ, Borggrefe M, et al. ACC/AHA/ESC 2006 Guidelines for management of patients with ventricular arrhythmias and prevention of sudden cardiac death - executive summary. J Am Coll Cardiol ,2006, 48 : 1064-1108.
5The AFFIRM First Antiarrhythmic Dnlg Substudy Investigators. Maintenance of sinus rhythm in patients with atrial fibrillation: An AFFIRM substudy of the first antiarrhythmic drug adminislered.J Am Coil Cardiol ,2003,42 : 20-29.
6Sadowski ZP, Alexander JH,Skrabucha B,et al.Muhicenter randomized trial and a systematic overview of lidocaine in acute myocardial infarction. Am Heart J, 1999,137 : 792-798.
7Roden DM.M~hanisms and management of proarrhythmia. Am J Caridiol, 1998,82 : 491-571.
9Drouin E, Lande Go Charpentier F.Amiodarone reducers transmural heterogrmity of re.polarization in the human heart. J Am Coll Cardiol, 1998,32 : 1063-1067.
10Teo KK, Yusuf S.Overview of antiarrhythmic drug trail: Implications for antiarrhythmictherapy. Cardiovascular Pharmacology and Tcrapeutics. New York:Churchill Livingstome, 1994 : 631-643.
